173 related articles for article (PubMed ID: 22872143)
21. First episode and recurrent venous thromboembolism: who is identifiably at risk?
Liem TK; Deloughery TG
Semin Vasc Surg; 2008 Sep; 21(3):132-8. PubMed ID: 18774448
[TBL] [Abstract][Full Text] [Related]
22. Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.
Kearon C
Clin Chest Med; 2010 Dec; 31(4):719-30. PubMed ID: 21047578
[TBL] [Abstract][Full Text] [Related]
23. Predicting the risk of recurrent venous thromboembolism (VTE).
Streiff MB
J Thromb Thrombolysis; 2015 Apr; 39(3):353-66. PubMed ID: 25721218
[TBL] [Abstract][Full Text] [Related]
24. D-dimer levels and risk of recurrent venous thromboembolism.
Eichinger S; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Weltermann A; Wagner O; Kyrle PA
JAMA; 2003 Aug; 290(8):1071-4. PubMed ID: 12941680
[TBL] [Abstract][Full Text] [Related]
25. Medical therapy in venous thromboembolism.
Eichinger S; Kyrle PA
Semin Respir Crit Care Med; 2012 Apr; 33(2):186-90. PubMed ID: 22648491
[TBL] [Abstract][Full Text] [Related]
26. Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.
Rodger M; Carrier M; Gandara E; Le Gal G
Blood Rev; 2010; 24(4-5):171-8. PubMed ID: 20633967
[TBL] [Abstract][Full Text] [Related]
27. Duration of anticoagulation: applying the guidelines and beyond.
Bauer KA
Hematology Am Soc Hematol Educ Program; 2010; 2010():210-5. PubMed ID: 21239796
[TBL] [Abstract][Full Text] [Related]
28. Recurrent venous thromboembolism.
Galioto NJ; Danley DL; Van Maanen RJ
Am Fam Physician; 2011 Feb; 83(3):293-300. PubMed ID: 21302870
[TBL] [Abstract][Full Text] [Related]
29. Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism.
Kearon C
Curr Opin Hematol; 2012 Sep; 19(5):363-70. PubMed ID: 22759630
[TBL] [Abstract][Full Text] [Related]
30. Duration of anticoagulant therapy for patients with venous thromboembolism.
Garcia D
Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
[TBL] [Abstract][Full Text] [Related]
31. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism in pregnancy.
James AH
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers and venous thromboembolism.
Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):332-6. PubMed ID: 19228607
[TBL] [Abstract][Full Text] [Related]
34. Assessing recurrence risk following acute venous thromboembolism: use of algorithms.
Poli D; Palareti G
Curr Opin Pulm Med; 2013 Sep; 19(5):407-12. PubMed ID: 23912189
[TBL] [Abstract][Full Text] [Related]
35. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
36. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
38. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
Couturaud F; Kearon C
Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
Chunilal SD; Bates SM
Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
[TBL] [Abstract][Full Text] [Related]
40. How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.
Palareti G
Expert Rev Hematol; 2015 Feb; 8(1):79-88. PubMed ID: 25348806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
